Skip to main content
Equibles

GSA CAPITAL PARTNERS LLP

Position in ANIK — Anika Therapeutics, Inc.

CIK 1362033 LONDON, X0
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$383,057
+$71,742 QoQ
Shares Held
26,183
+22.0% QoQ
Ownership
0.196%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#53
of 134 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $11,914,926 across 21 Drug Manufacturers - Specialty & Generic names. ANIK ranks #12 (3.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INDV
Indivior Pharmaceuticals, Inc.
 55,201 $2,264,897
2 ZTS
Zoetis Inc.
 18,470 $1,327,254
3 IRWD
Ironwood Pharmaceuticals Inc
 259,512 $1,092,545
4 BCRX
Biocryst Pharmaceuticals Inc
 90,210 $902,100
5 LQDA
Liquidia Corp
 10,098 $805,113
6 KNSA
Kiniksa Pharmaceuticals International, plc
 11,219 $717,455
7 AMLX
Amylyx Pharmaceuticals, Inc.
 39,241 $704,768
8 XERS
Xeris Biopharma Holdings, Inc.
 82,830 $656,013

All Filings in ANIK

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $383,057 26,183
2026-03-31 $311,315 21,470
2025-12-31 $1,173,015 122,062
2025-09-30 $392,384 41,743
2024-12-31 $190,540 11,576
2024-09-30 $777,432 31,475
2024-06-30 $1,002,105 39,562
2024-03-31 $1,113,459 43,837
2023-12-31 $1,322,800 58,376
2023-09-30 $962,015 51,638
2023-03-31 $537,896 18,729
2021-12-31 $348,160 9,717
2021-09-30 $826,557 19,421
2021-06-30 $1,768,612 40,855
2021-03-31 $590,231 14,470
2020-03-31 $325,902 11,273